+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Minimally Invasive Glaucoma Surgery Devices Market - Global Forecast 2026-2032- Product Image
Minimally Invasive Glaucoma Surgery Devices Market - Global Forecast 2026-2032- Product Image
New

Minimally Invasive Glaucoma Surgery Devices Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 198 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968801
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The minimally invasive glaucoma surgery devices market continues to evolve as healthcare leaders respond to changing clinical needs, competitive challenges, and operational priorities. Senior executives must navigate this dynamic environment by aligning strategy with the latest technological advances and regulatory demands.

Market Snapshot: Minimally Invasive Glaucoma Surgery Devices

The minimally invasive glaucoma surgery devices market is expanding, shaped by increasing demand for advanced surgical techniques that emphasize patient-centric care and more favorable clinical outcomes. Senior leaders recognize a shift in surgeon preferences, broader adoption of innovative devices, and a greater variety of therapeutic pathways. The market landscape is defined by ongoing device innovation, emergence of new procurement models, and heightened focus on value-based healthcare delivery.

Scope & Segmentation

  • Device Types: Includes ablation tools, catheter systems, lumen-based shunts (both fixed-lumen and flow-controlled), scaffolds or expanders, and stents. These devices play distinct roles in supporting varied surgical workflows and adapting to institutional needs.
  • Surgical Sites: Applied to anatomical locations such as the ciliary body, Schlemm’s canal, subconjunctival space, suprachoroidal region, and trabecular meshwork. Each site introduces specific clinical considerations, training requirements, and suitability for standalone or combined procedures.
  • Clinical Indications: Product portfolios are designed for primary open-angle glaucoma, angle-closure glaucoma, congenital glaucoma, and secondary glaucoma. Segmenting by indication ensures solutions remain adaptable for diverse patient populations and evolving trial frameworks.
  • Surgical Approaches: Ab interno and ab externo approaches shape device use, instrument design, and perioperative protocols, and drive adoption in both hospital and ambulatory care settings.
  • Implant Materials: Typical materials include nitinol, titanium, gelatin, polyethersulfone, polyimide, and silicone. Advances in material science and regulatory requirements influence device selection and clinical performance.
  • End Users & Distribution: Devices are used across ambulatory surgery centers, ophthalmic clinics, specialty eye hospitals, with both online and offline distribution networks supporting commercialization and ongoing servicing models.
  • Regional Scope: Coverage spans the Americas, Europe, Middle East & Africa, and Asia-Pacific. Market dynamics vary by region due to differences in healthcare infrastructure, reimbursement policies, and regulatory frameworks.

Key Takeaways for Executive Strategy

  • Clinical integration of minimally invasive glaucoma surgery devices is progressing as surgeons adopt workflows that support improved patient recovery and operational efficiency.
  • Manufacturers are responding to practitioner feedback by advancing device materials and enhancing lumen control, expanding the range and usability of available technologies in clinical practice.
  • Hospital procurement strategies are shifting towards value-based care models, with payers emphasizing strong evidence of clinical benefit and economic viability.
  • Competitive advantage is increasingly determined by robust training resources, intellectual property protection, and long-term clinical partnerships, reducing reliance on incremental product changes.
  • Market access must be customized for diverse user environments, aligning commercial and educational strategies with local regulatory standards and practitioner capabilities.

Tariff Impact and Supply Chain Resilience

Recent changes in US medical device tariffs are encouraging manufacturers and healthcare providers to enhance supply chain resilience. Organizations are regionalizing production, expanding their base of component suppliers, and adopting modular device designs that can respond to shifting trade dynamics. Risk-sharing in procurement and focus on total landed cost contribute to maintaining market accessibility and controlling costs despite regulatory volatility.

Methodology & Data Sources

This market analysis is based on structured interviews with leading surgeons, engineers, and procurement specialists, combined with clinical literature reviews, regulatory documentation, and workflow observations. Secondary research leverages patent databases and technology roadmaps, each source validated to enhance sector credibility.

Why This Report Matters

  • Empowers executive teams to proactively address changes in market, regulatory, and procurement environments for minimally invasive glaucoma surgery devices.
  • Supports segmentation and operational risk management across regions, care settings, and diverse patient populations for stronger competitive positioning.
  • Provides evidence-based recommendations for optimizing supply chain flexibility and developing effective commercialization strategies.

Conclusion

Ongoing alignment of clinical innovation, supply chain management, and localized commercial strategy is essential for sustainable success in the minimally invasive glaucoma surgery devices market. Executives prepared to address these priorities will help lead sector progress as operational challenges and market expectations develop.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2024
3.5. FPNV Positioning Matrix, 2024
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Minimally Invasive Glaucoma Surgery Devices Market, by Device Type
8.1. Ablation Tools
8.2. Catheter
8.3. Lumen-Based Shunts
8.3.1. Fixed-Lumen
8.3.2. Flow-Controlled
8.4. Scaffold/Expander
8.5. Stents
9. Minimally Invasive Glaucoma Surgery Devices Market, by Surgical Site
9.1. Ciliary Body
9.2. Schlemm’s Canal
9.3. Subconjunctival Space
9.4. Suprachoroidal Space
9.5. Trabecular Meshwork
10. Minimally Invasive Glaucoma Surgery Devices Market, by Indication
10.1. Angle-Closure Glaucoma
10.2. Congenital Glaucoma
10.3. Primary Open Angle Glaucoma
10.4. Secondary Glaucoma
11. Minimally Invasive Glaucoma Surgery Devices Market, by Surgical Approach
11.1. Ab Externo
11.2. Ab Interno
12. Minimally Invasive Glaucoma Surgery Devices Market, by Procedure Type
12.1. Combined With Cataract Surgery
12.2. Standalone Procedure
13. Minimally Invasive Glaucoma Surgery Devices Market, by Implant Material
13.1. Metals
13.1.1. Nitinol
13.1.2. Titanium
13.2. Polymers
13.2.1. Gelatin
13.2.2. Polyethersulfone
13.2.3. Polyimide
13.2.4. Silicone
14. Minimally Invasive Glaucoma Surgery Devices Market, by Device Class
14.1. Implantable
14.2. Non-implantable
15. Minimally Invasive Glaucoma Surgery Devices Market, by Payment Method
15.1. Reimbursement-Based
15.2. Self-Pay
16. Minimally Invasive Glaucoma Surgery Devices Market, by Patient Type
16.1. Pediatric
16.2. Adult
17. Minimally Invasive Glaucoma Surgery Devices Market, by Usability
17.1. Reusable
17.2. Disposable
18. Minimally Invasive Glaucoma Surgery Devices Market, by End User
18.1. Ambulatory Surgery Centers
18.2. Ophthalmic Clinics
18.3. Specialty Eye Hospitals
19. Minimally Invasive Glaucoma Surgery Devices Market, by Distribution Channel
19.1. Offline
19.2. Online
20. Minimally Invasive Glaucoma Surgery Devices Market, by Region
20.1. Americas
20.1.1. North America
20.1.2. Latin America
20.2. Europe, Middle East & Africa
20.2.1. Europe
20.2.2. Middle East
20.2.3. Africa
20.3. Asia-Pacific
21. Minimally Invasive Glaucoma Surgery Devices Market, by Group
21.1. ASEAN
21.2. GCC
21.3. European Union
21.4. BRICS
21.5. G7
21.6. NATO
22. Minimally Invasive Glaucoma Surgery Devices Market, by Country
22.1. United States
22.2. Canada
22.3. Mexico
22.4. Brazil
22.5. United Kingdom
22.6. Germany
22.7. France
22.8. Russia
22.9. Italy
22.10. Spain
22.11. China
22.12. India
22.13. Japan
22.14. Australia
22.15. South Korea
23. United States Minimally Invasive Glaucoma Surgery Devices Market
24. China Minimally Invasive Glaucoma Surgery Devices Market
25. Competitive Landscape
25.1. Market Concentration Analysis, 2024
25.1.1. Concentration Ratio (CR)
25.1.2. Herfindahl Hirschman Index (HHI)
25.2. Recent Developments & Impact Analysis, 2024
25.3. Product Portfolio Analysis, 2024
25.4. Benchmarking Analysis, 2024
25.5. AbbVie Inc.
25.6. Alcon Vision LLC
25.7. Bausch + Lomb Corp.
25.8. BVI Medical, Inc.
25.9. Chengdu Kanghong Pharmaceutical Group Co., Ltd.
25.10. Glaukos Corporation
25.11. Haag-Streit Group by Metall Zug AG
25.12. Iridex Corporation
25.13. iSTAR Medical
25.14. Johnson & Johnson Services, Inc.
25.15. Lumibird Medical
25.16. New World Medical, Inc.
25.17. Nova Eye Medical Limited
25.18. Oertli Instrumente AG
25.19. Santen Pharmaceutical Co., Ltd.
List of Figures
FIGURE 1. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 3. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 4. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 15. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 17. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 19. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 20. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ABLATION TOOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ABLATION TOOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ABLATION TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CATHETER, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CATHETER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY FIXED-LUMEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY FIXED-LUMEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY FIXED-LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY FLOW-CONTROLLED, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY FLOW-CONTROLLED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY FLOW-CONTROLLED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SCAFFOLD/EXPANDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SCAFFOLD/EXPANDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SCAFFOLD/EXPANDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CILIARY BODY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CILIARY BODY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CILIARY BODY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SCHLEMM’S CANAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SCHLEMM’S CANAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SCHLEMM’S CANAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL SPACE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL SPACE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL SPACE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SPACE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SPACE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SPACE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MESHWORK, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MESHWORK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MESHWORK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ANGLE-CLOSURE GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ANGLE-CLOSURE GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ANGLE-CLOSURE GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONGENITAL GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONGENITAL GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONGENITAL GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SECONDARY GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SECONDARY GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SECONDARY GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AB EXTERNO, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AB EXTERNO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AB EXTERNO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AB INTERNO, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AB INTERNO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AB INTERNO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COMBINED WITH CATARACT SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COMBINED WITH CATARACT SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COMBINED WITH CATARACT SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STANDALONE PROCEDURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STANDALONE PROCEDURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STANDALONE PROCEDURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GELATIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GELATIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GELATIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYETHERSULFONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYETHERSULFONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYETHERSULFONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYIMIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYIMIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYIMIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY NON-IMPLANTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY NON-IMPLANTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY NON-IMPLANTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REIMBURSEMENT-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REIMBURSEMENT-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REIMBURSEMENT-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELF-PAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELF-PAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELF-PAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SPECIALTY EYE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SPECIALTY EYE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SPECIALTY EYE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 205. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 206. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 207. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
TABLE 208. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
TABLE 209. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 210. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
TABLE 211. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 212. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 213. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
TABLE 214. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
TABLE 215. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
TABLE 216. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
TABLE 217. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 218. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
TABLE 219. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
TABLE 235. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 237. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 239. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
TABLE 240. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
TABLE 241. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 242. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
TABLE 243. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 244. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 245. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
TABLE 246. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
TABLE 247. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
TABLE 248. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
TABLE 249. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 250. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
TABLE 251. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 252. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
TABLE 257. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 258. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
TABLE 259. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 260. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
TABLE 263. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
TABLE 264. ASIA-PACIFIC MI

Companies Mentioned

The key companies profiled in this Minimally Invasive Glaucoma Surgery Devices market report include:
  • AbbVie Inc.
  • Alcon Vision LLC
  • Avisi Technologies, Inc.
  • Bausch + Lomb Corp.
  • BVI Medical, Inc.
  • Chengdu Kanghong Pharmaceutical Group Co., Ltd.
  • Corza Ophthalmology Products, Inc.
  • Glaukos Corporation
  • Haag-Streit Group by Metall Zug AG
  • Iridex Corporation
  • iSTAR Medical
  • Johnson & Johnson Services, Inc.
  • Lantrek, Inc.
  • LIQID Medical (Pty) Ltd.
  • Lumenis Be Ltd.
  • Lumibird Medical
  • New World Medical, Inc.
  • Nova Eye Medical Limited
  • Oertli Instrumente AG
  • Rheon Medical SA
  • Santen Pharmaceutical Co., Ltd.
  • Sight Sciences, Inc.
  • Ziemer Ophthalmic Systems AG

Table Information

Report AttributeDetails
No. of Pages198
PublishedJanuary 2026
Forecast Period2025 - 2032
Estimated Market Value ( USD ) in 2025 $ 635.51 Million
Forecasted Market Value ( USD ) by 2032 $ 944.8 Million
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report 2025 - Product Image

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Glaucoma Drainage Devices Market - Global Forecast 2025-2030 - Product Image

Glaucoma Drainage Devices Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Implantable Glaucoma Device Market - Global Forecast 2025-2030 - Product Image

Implantable Glaucoma Device Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Glaucoma Surgery Devices Market Report and Forecast 2025-2034 - Product Image

Glaucoma Surgery Devices Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Glaucoma Surgery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Glaucoma Surgery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From

About the Minimally Invasive Glaucoma Surgery Devices Market

Minimally Invasive Glaucoma Surgery (MIGS) devices are a subset of surgical devices designed for the treatment of glaucoma, a chronic eye condition that leads to increased intraocular pressure (IOP) and can result in vision loss. These devices offer a less invasive alternative to traditional glaucoma surgeries, aiming to reduce IOP by improving aqueous humor outflow from the eye. MIGS procedures typically involve micro-scale incisions and implants, promising reduced recovery times and a lower risk of complications compared to conventional surgical methods. The market for MIGS devices overlaps with the broader ophthalmic surgical device market and aligns with an increasing demand for surgeries that provide symptom relief while minimizing tissue trauma. The development and adoption of MIGS devices have been influenced by technological advances, the rising prevalence of glaucoma, and the prioritization of patient quality of life and surgical outcomes. As a niche within surgical devices, MIGS products often require specialized training for surgeons and are accompanied by ongoing research and development to optimize their efficacy and safety profiles. In the market for MIGS devices, several companies are prominent, including Glaukos Corporation, Ivantis Inc., Alcon, a division of Novartis, and Johnson & Johnson Vision, a subsidiary of Johnson & Johnson. Other players include Allergan (now part of AbbVie), and New World Medical, which also contribute to the research, development, and distribution of these specialized surgical instruments for gl Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.